Insights On Drug Development
-
Amorphous Solids: Implications For Solubility And Stability
5/6/2026
Amorphous solids can enhance drug solubility and bioavailability but introduce stability risks, making careful characterization and control essential for successful pharmaceutical development and manufacturing.
-
Accelerating Small Molecule Protein Degrader Development Using High-Content Imaging
5/6/2026
High‑content imaging enables rapid discovery and optimization of small‑molecule protein degraders by delivering multiparametric, single‑cell insights that accelerate hit identification, SAR development, and lead advancement.
-
Accelerating Discovery Success With Structure-Guided Drug Design
5/6/2026
Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.
-
Chirality In Drug Development: From Racemic Mixtures To Enantiopure Substances
5/6/2026
Chiral crystallization enables efficient production of enantiopure drug substances, improving pharmacological control and safety while supporting scalable, cost‑effective small molecule development.
-
Deciphering Nanoparticle Properties With AF4
5/6/2026
Discover how risk‑based, phase‑appropriate synthesis enables safe, efficient production of highly potent compounds while balancing speed, worker safety, and regulatory readiness in early development.
-
Drug Substance For Early Clinical Phase Initiation
5/6/2026
Explore how proactive nitrosamine impurity risk assessment protects early clinical drug supply, minimizes development delays, and enables confident progression to first‑in‑human studies.
-
Accelerating Drug Development: Solid State Chemistry And Strategic Outsourcing
5/6/2026
Discover how phase‑appropriate solid‑state chemistry and strategic outsourcing reduce risk, speed development timelines, and enable confident solid‑form selection for complex small‑molecule programs.
-
A Simple And Powerful Solution For Accelerating Dissolution
5/5/2026
Many poorly soluble drugs fail not because of low solubility, but because they dissolve too slowly. Learn how focusing on dissolution rate can unlock absorption gains using simple strategies.
-
Advancing Cell Culture Strategies To Accelerate Biologics Development
5/5/2026
Integrated stable expression strategies accelerate biologics material generation, improving scalability, consistency, and early developability insights while reducing bottlenecks, variability, and risks in transitioning from discovery to manufacturing.
-
Spray Dried Biologics For Injectable Dosage Forms
5/1/2026
Experts highlight spray drying as a gentle, scalable way to stabilize biologics, supporting high‑concentration injectables with controlled particles, sterility, and flexible delivery.